Chemed Net Receivables vs Deferred Long Term Liab Analysis

CHE Stock

USD 547.79 0.53 0.1%

Chemed Corp financial indicator trend analysis is way more than just evaluating Chemed Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemed Corp is a good investment. Please check the relationship between Chemed Corp Net Receivables and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

Net Receivables vs Deferred Long Term Liab

Net Receivables vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemed Corp Net Receivables account and Deferred Long Term Liab. At this time, the significance of the direction appears to have no relationship.

The correlation between Chemed Corp's Net Receivables and Deferred Long Term Liab is 0.0. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Chemed Corp, assuming nothing else is changed. The correlation between historical values of Chemed Corp's Net Receivables and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Chemed Corp are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Receivables i.e., Chemed Corp's Net Receivables and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Net Receivables

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Chemed Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemed Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.At present, Chemed Corp's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 22.03, whereas Selling General Administrative is forecasted to decline to about 216.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	769.8M	765.1M	796.6M	836.4M
Total Revenue	2.1B	2.1B	2.3B	2.4B

Gross Profit Total Revenue

Chemed Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity
Total Assets		0.49	0.75	0.62	0.97	0.94	-0.3	0.97	0.74	0.98	0.3	0.74	0.66	0.62	-0.77	0.56	-0.26	0.67	-0.91	0.71	0.9	0.86	-0.06	0.8	0.29	0.7
Short Long Term Debt Total	0.49		0.43	0.61	0.27	0.54	0.57	0.46	0.07	0.57	-0.38	0.07	0.37	0.54	-0.28	0.81	-0.21	0.68	-0.57	0.86	0.27	0.19	0.28	0.64	0.64	0.41
Other Current Liab	0.75	0.43		0.36	0.72	0.78	-0.31	0.8	0.69	0.7	0.21	0.69	0.34	0.29	-0.5	0.55	0.13	0.43	-0.79	0.55	0.75	0.73	0.04	0.61	0.36	0.32
Total Current Liabilities	0.62	0.61	0.36		0.51	0.59	0.09	0.55	0.33	0.66	-0.17	0.33	0.62	0.73	-0.53	0.38	-0.43	0.8	-0.58	0.82	0.37	0.41	0.17	0.65	0.39	0.69
Total Stockholder Equity	0.97	0.27	0.72	0.51		0.89	-0.5	0.94	0.82	0.92	0.47	0.82	0.62	0.52	-0.75	0.39	-0.2	0.53	-0.85	0.54	0.93	0.91	-0.12	0.71	0.13	0.64
Property Plant And Equipment Net	0.94	0.54	0.78	0.59	0.89		-0.16	0.96	0.62	0.94	0.16	0.62	0.66	0.52	-0.83	0.64	-0.06	0.61	-0.95	0.74	0.86	0.75	-0.24	0.89	0.38	0.56
Net Debt	-0.3	0.57	-0.31	0.09	-0.5	-0.16		-0.29	-0.77	-0.13	-0.85	-0.77	-0.01	0.22	0.16	0.47	-0.24	0.19	0.12	0.34	-0.54	-0.67	0.04	0.1	0.47	0.02
Retained Earnings	0.97	0.46	0.8	0.55	0.94	0.96	-0.29		0.71	0.94	0.3	0.71	0.67	0.52	-0.85	0.57	-0.11	0.64	-0.98	0.68	0.92	0.84	-0.22	0.75	0.27	0.62
Cash	0.74	0.07	0.69	0.33	0.82	0.62	-0.77	0.71		0.59	0.76	1.0	0.26	0.11	-0.41	0.05	0.15	0.28	-0.58	0.22	0.87	0.97	0.16	0.36	-0.1	0.26
Non Current Assets Total	0.98	0.57	0.7	0.66	0.92	0.94	-0.13	0.94	0.59		0.11	0.59	0.7	0.73	-0.78	0.66	-0.37	0.72	-0.91	0.8	0.8	0.73	-0.1	0.87	0.39	0.77
Non Currrent Assets Other	0.3	-0.38	0.21	-0.17	0.47	0.16	-0.85	0.3	0.76	0.11		0.76	0.0	-0.33	-0.1	-0.38	0.39	-0.17	-0.14	-0.34	0.63	0.7	0.05	-0.13	-0.5	-0.11
Cash And Short Term Investments	0.74	0.07	0.69	0.33	0.82	0.62	-0.77	0.71	1.0	0.59	0.76		0.26	0.11	-0.41	0.05	0.15	0.28	-0.58	0.22	0.87	0.97	0.16	0.36	-0.1	0.26
Net Receivables	0.66	0.37	0.34	0.62	0.62	0.66	-0.01	0.67	0.26	0.7	0.0	0.26		0.75	-0.78	0.57	-0.41	0.56	-0.7	0.72	0.52	0.42	-0.37	0.63	0.36	0.82
Good Will	0.62	0.54	0.29	0.73	0.52	0.52	0.22	0.52	0.11	0.73	-0.33	0.11	0.75		-0.49	0.65	-0.83	0.73	-0.53	0.83	0.26	0.23	0.07	0.65	0.51	0.96
Common Stock Shares Outstanding	-0.77	-0.28	-0.5	-0.53	-0.75	-0.83	0.16	-0.85	-0.41	-0.78	-0.1	-0.41	-0.78	-0.49		-0.45	0.16	-0.56	0.87	-0.59	-0.7	-0.58	0.59	-0.65	-0.21	-0.6
Non Current Liabilities Total	0.56	0.81	0.55	0.38	0.39	0.64	0.47	0.57	0.05	0.66	-0.38	0.05	0.57	0.65	-0.45		-0.29	0.59	-0.67	0.84	0.34	0.2	-0.07	0.69	0.71	0.56
Inventory	-0.26	-0.21	0.13	-0.43	-0.2	-0.06	-0.24	-0.11	0.15	-0.37	0.39	0.15	-0.41	-0.83	0.16	-0.29		-0.49	0.1	-0.43	0.12	0.07	-0.15	-0.23	-0.27	-0.79
Other Current Assets	0.67	0.68	0.43	0.8	0.53	0.61	0.19	0.64	0.28	0.72	-0.17	0.28	0.56	0.73	-0.56	0.59	-0.49		-0.69	0.83	0.43	0.41	0.12	0.56	0.5	0.73
Other Stockholder Equity	-0.91	-0.57	-0.79	-0.58	-0.85	-0.95	0.12	-0.98	-0.58	-0.91	-0.14	-0.58	-0.7	-0.53	0.87	-0.67	0.1	-0.69		-0.76	-0.84	-0.74	0.26	-0.75	-0.37	-0.61
Total Liab	0.71	0.86	0.55	0.82	0.54	0.74	0.34	0.68	0.22	0.8	-0.34	0.22	0.72	0.83	-0.59	0.84	-0.43	0.83	-0.76		0.43	0.36	0.06	0.81	0.67	0.75
Property Plant And Equipment Gross	0.9	0.27	0.75	0.37	0.93	0.86	-0.54	0.92	0.87	0.8	0.63	0.87	0.52	0.26	-0.7	0.34	0.12	0.43	-0.84	0.43		0.95	-0.14	0.6	0.1	0.41
Total Current Assets	0.86	0.19	0.73	0.41	0.91	0.75	-0.67	0.84	0.97	0.73	0.7	0.97	0.42	0.23	-0.58	0.2	0.07	0.41	-0.74	0.36	0.95		0.03	0.49	-0.01	0.39
Short Term Debt	-0.06	0.28	0.04	0.17	-0.12	-0.24	0.04	-0.22	0.16	-0.1	0.05	0.16	-0.37	0.07	0.59	-0.07	-0.15	0.12	0.26	0.06	-0.14	0.03		-0.12	-0.03	-0.03
Intangible Assets	0.8	0.64	0.61	0.65	0.71	0.89	0.1	0.75	0.36	0.87	-0.13	0.36	0.63	0.65	-0.65	0.69	-0.23	0.56	-0.75	0.81	0.6	0.49	-0.12		0.53	0.58
Accounts Payable	0.29	0.64	0.36	0.39	0.13	0.38	0.47	0.27	-0.1	0.39	-0.5	-0.1	0.36	0.51	-0.21	0.71	-0.27	0.5	-0.37	0.67	0.1	-0.01	-0.03	0.53		0.41
Common Stock Total Equity	0.7	0.41	0.32	0.69	0.64	0.56	0.02	0.62	0.26	0.77	-0.11	0.26	0.82	0.96	-0.6	0.56	-0.79	0.73	-0.61	0.75	0.41	0.39	-0.03	0.58	0.41

Click cells to compare fundamentals

Chemed Corp Account Relationship Matchups

Chemed Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.3B	1.4B	1.3B	1.4B	1.7B	1.8B
Short Long Term Debt Total	215.9M	135.4M	323.5M	247.0M	155.1M	149.1M
Other Current Liab	43.8M	199.2M	191.4M	192.8M	202.5M	212.6M
Total Current Liabilities	262.2M	299.1M	302.4M	297.2M	312.1M	167.5M
Total Stockholder Equity	726.6M	901.2M	623.3M	798.7M	1.1B	1.2B
Property Plant And Equipment Net	287.4M	311.3M	318.7M	335.4M	330.2M	346.7M
Net Debt	209.8M	(27.3M)	290.6M	172.9M	(108.8M)	(103.4M)
Retained Earnings	1.4B	1.7B	2.0B	2.2B	2.4B	2.6B
Cash	6.2M	162.7M	32.9M	74.1M	264.0M	277.2M
Non Current Assets Total	1.1B	1.1B	1.1B	1.2B	1.2B	1.2B
Non Currrent Assets Other	(9.5M)	(11.9M)	(88.2M)	(37.3M)	161.7M	169.8M
Cash And Short Term Investments	6.2M	162.7M	32.9M	74.1M	264.0M	277.2M
Net Receivables	143.8M	126.9M	137.2M	139.4M	181.5M	93.9M
Good Will	577.4M	578.6M	578.6M	581.3M	585.0M	339.2M
Common Stock Shares Outstanding	16.5M	16.4M	15.9M	15.1M	15.2M	15.9M
Liabilities And Stockholders Equity	1.3B	1.4B	1.3B	1.4B	1.7B	1.8B
Non Current Liabilities Total	279.5M	234.6M	417.1M	346.1M	248.2M	194.5M
Inventory	7.5M	7.1M	10.1M	10.3M	12.0M	16.1M
Other Current Assets	33.2M	32.8M	50.1M	48.8M	43.4M	31.9M
Other Stockholder Equity	(737.3M)	(861.2M)	(1.4B)	(1.4B)	(1.4B)	(1.3B)
Total Liab	541.7M	533.7M	719.5M	643.3M	560.2M	362.0M
Property Plant And Equipment Gross	287.4M	311.3M	318.7M	335.4M	685.1M	719.4M
Total Current Assets	190.7M	329.4M	230.3M	272.6M	500.8M	525.9M
Accumulated Other Comprehensive Income	2.3M	2.3M	2.2M	2.2M	2.1M	2.2M
Short Term Debt	39.3M	36.2M	37.9M	44.0M	54.3M	57.1M
Intangible Assets	126.4M	118.1M	108.1M	99.7M	90.3M	87.4M
Accounts Payable	51.1M	54.2M	73.0M	41.9M	48.3M	39.9M
Common Stock Total Equity	35.3M	35.8M	36.3M	36.5M	42.0M	30.2M
Common Stock	35.8M	36.3M	36.5M	36.8M	37.2M	31.1M
Other Liab	102.8M	135.4M	131.4M	143.1M	164.5M	172.8M
Other Assets	86.5M	408.8M	107.0M	58.0M	66.7M	71.8M
Treasury Stock	(1.4B)	(1.6B)	(1.8B)	(2.4B)	(2.2B)	(2.1B)
Property Plant Equipment	175.8M	187.8M	318.7M	335.4M	385.7M	405.0M
Current Deferred Revenue	128.1M	166.1M	152.4M	38.6M	6.9M	6.5M
Net Tangible Assets	22.9M	204.5M	(63.4M)	108.8M	125.1M	131.4M
Retained Earnings Total Equity	1.2B	1.4B	1.7B	2.0B	2.3B	2.4B
Long Term Debt Total	90M	0.0	185M	92.5M	83.3M	91.6M
Capital Surpluse	860.7M	961.4M	1.0B	1.1B	1.3B	757.3M
Deferred Long Term Liab	95.0M	109.1M	121.8M	1.7M	2.0M	1.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:

How To Invest In Chemed

Details

Is Chemed Stock a good investment?

Details

What is Chemed Corp's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.014

Dividend Share

1.7

Earnings Share

19.78

Revenue Per Share

157.577

Quarterly Revenue Growth

0.074

The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemed Net Receivables vs Deferred Long Term Liab Analysis

Net Receivables vs Deferred Long Term Liab

Net Receivables vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Net Receivables

Deferred Long Term Liab

Chemed Corp fundamental ratios Correlations

Chemed Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemed Corp fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.98	Total Assets
Total Stockholder Equity	+ 0.97	Total Assets
Retained Earnings	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments

Other Stockholder Equity	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.95	Property Plant And Equipment Net
Other Stockholder Equity	- 0.91	Non Current Assets Total
Other Stockholder Equity	- 0.91	Total Assets
Common Stock Shares Outstanding	- 0.85	Retained Earnings
Non Currrent Assets Other	- 0.85	Net Debt